SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARADIGM CORP. ARDM
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
255 21 0 ARDM
Emcee:  Marvin Frank Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
30biz.yahoo.comscaram(o)uche-5/4/1999
29 News out on private placement. $2.5 m at about $10 a share. This should help Phil Cressman-1/27/1999
28 Phil, Do a search for Aradigm on this site diabetes.org You'll get a techniRobert Parker-1/13/1999
27 Phil, The device I was using was desk bound and about the size of a loaf of breRobert Parker-1/12/1999
26 Robert it is really great to have a contributor who has actually used the systePhil Cressman-1/12/1999
25 Hi All, Just joining in and new to this site. Have been following ARDM for a whRobert Parker-1/6/1999
24 To All: Finally some news on Aradigm: Warburg Dillon Read issued a Company Reshoe-12/7/1998
23 I haven't seen mention of this from the August 14 quarterly report. Jasotnsaf-8/30/1998
22 Dear AGS, I have not followed DURA and know nothing about it. Marvin Frank-6/19/1998
21 How does DURA Pharm. Co. figure in the inhaler market? A. G. S.-6/18/1998
20 Dear Richard, From what I understand, ARDM already has a patented device capabMarvin Frank-6/18/1998
19 Marvin, Thanks. Do you know when either company gets a patent, does it coverRichard Wang-6/17/1998
18 Dear Richard, The recent WSJ article about Pfizer and INHL was responsible forMarvin Frank-6/17/1998
17 No I don't... Gregg Gregg Soster-6/17/1998
16 Any idea who is ahead, ARDM or INHL? Thanks, RichardRichard Wang-6/17/1998
15 Dunno, I think LLY may have the mindshare that the "next big thing" iGregg Soster-6/9/1998
14 The problem may be that it's only a Phase II trial, though that didn't shoe-6/9/1998
13 Scratching my head... looks like the news was leaked, thus the rise from $13 toStockJock-e-6/5/1998
12 Anyone notice the 300,000 block that went off today. Was this a sell or a buy? rebecca-6/4/1998
11 Dear Edwin, Agree that ARDM stock should have responded to the new Novo deal bMarvin Frank-6/4/1998
10 If it's such a great deal, why isn't the stock responding?Edwin Slonim-6/4/1998
9 I couldn't agree more. I watched Eli Lilly's new pen device with anticGregg Soster-6/4/1998
8 Jim Silverman, Cost<Reward Capital Management, drew my attention to this onescaram(o)uche-6/3/1998
7 I'm in and I just got wind of a size buyer at one of the firms which followAllen B.-5/1/1998
6 The catalyst for this stock would be approval for inhalation of drug as insulinMarvin Frank-4/29/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):